Back to search

Article

Levetiracetam Modulates Brain Metabolic Networks and Transcriptomic Signatures in the 5XFAD Mouse Model of Alzheimer’s disease

2023-11-14

Abstract excerpt

<h4>ABSTRACT</h4> <h4>INTRODUCTION</h4> Subcritical epileptiform activity is associated with impaired cognitive function and is commonly seen in patients with Alzheimer’s disease (AD). The anti-convulsant, levetiracetam (LEV), is currently being evaluated in clinical trials for its ability to reduce epileptiform activity and improve cognitive function in AD. The purpose of the current study was to apply pharmaco...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
db74b0c3-6bc3-55c2-89c8-c14fe632f3e2
DOI
10.1101/2023.11.10.566574
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Levetiracetam Modulates Brain Metabolic Networks and Transcriptomic Signatures in the 5XFAD Mouse Model of Alzheimer’s diseaseDOI 10.1101/2023.11.10.566574
Select a neighboring publication to make it the new centre.